You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
AAV Mediated Gene Transfer to the CNS for MPS I
SBC: REGENX BIOSCIENCES, LLC Topic: NIDDKDESCRIPTION (provided by applicant): Mucopolysaccharidosis type I (MPS I) is an autosomal recessive storage disease caused by the absence of a-L-iduronidase (IDUA), resulting in systemic accumulation of glycosaminoglycan (GAG) storage materials, hepatosplenomegaly, skeletal dysplasias, cardiopulmonary obstruction, progressive neurologic impairment and death by age 15. MPS I is currently treated b ...
STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health -
A Universal Brain Atlas for Implanting and Managing Deep Brain Stimulators
SBC: Neurotargeting, LLC Topic: NIMHDESCRIPTION (provided by applicant): Deep brain stimulation has risen as a neurosurgical procedure of choice for patients with disabling neurological or psychiatric disorders for its abiliy to modulate improvement in the activity of certain circuits. The procedure is currently approved for treatment of Parkinson's disease (PD), essential tremor (ET), dystonia, and obsessive-compulsive disorde ...
STTR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Novel Methods for Dissolving Blood Clots
SBC: TRANSLATIONAL SCIENCES INC Topic: NHLBIDESCRIPTION (provided by applicant): Each year, as many as 2 million Americans develop venous thromboembolism (VTE). VTEs are blood clots in the legs (venous thrombosis) that may travel to the lungs (pulmonary embolism). It is estimated that 10-20% of VTEpatients die, and the annual direct costs are up to 10 billion. Despite advances in diagnosis and prophylaxis, anticoagulation, a 50-year-old th ...
STTR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Preclinical Development of a New Drug for Treating Anemia of Chronic Inflammation
SBC: CUMBERLAND PHARMACEUTICALS, INC. Topic: NIADESCRIPTION (provided by applicant): A strong unmet need exists to develop new treatments for anemias associated with chronic disease states, collectively referred to as anemia of chronic inflammation (ACI). ACI is highly prevalent in the U.S. and makes alarge contribution to public morbidity and mortality. Despite billions of dollars spent annually to treat ACI patients, current therapies lack e ...
STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health -
UCDS Unsteady Reaction Model
SBC: GLOYER-TAYLOR LABORATORIES INC Topic: MDA09T009The overall objective of the Phase II effort is to enhance the capability of the UCDS process to simulate and predict the characteristics of combustion instability in propulsion devices, specifically focusing on the propulsion devices used in missile defense applications. GTL shall apply proven techniques to rigorously develop a reaction wave model that is consistent with the rest of the UCDS pro ...
STTR Phase II 2012 Department of DefenseMissile Defense Agency